Pfizer earnings beat by $0.14, revenue topped estimates

Markets Investing.com By Investing.com 03 Nov 2026 11:53 1 min read
Pfizer earnings beat by $0.14, revenue topped estimates

Covered in this story

Analyst targets on Pfizer

Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.

Call it yourself

No member calls on $PFE yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.

Make the first call on Pfizer →

Dalsna Finance is currently tracking 48 stories mentioning Pfizer, the earliest published 14 Aug 2026.

Read the full story on Investing.com → Opens the original article on www.investing.com

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.